Child aged 6 weeks (March 2014).

Reason for consultation: presence of nasal mucus and cough since 3 weeks of life. During the last week there were more intense coughing spells at night, accompanied by peribuccal cyanosis on some occasions. Afebrile. No other symptoms reported.

Personal history:
- Controlled pregnancy with no notable incidents.
- Euthocic delivery at 40+6 weeks of gestational age. Birth weight 3,060 kg.
- Exclusive breastfeeding.
- Well vaccinated (1st dose HBV).

A. Family history:
- Mother aged 34 years presents seasonal allergic asthma, presenting catarrhal symptoms since 1 month, last 2 weeks refers cough predominantly at night which turns out to be very invalid, afebrile, no improvement with inhaled salbutamol. No other accompanying symptoms.
- Sister aged 2 years, healthy, correctly vaccinated. Currently asymptomatic.
- Father has allergic rhinoconjunctivitis.
- No other history of interest.

PHYSICAL EXAMINATION:
-Weight: 4.500 kg. Temperature 36.8oC. Sat O2 100%.
-Good general condition, good skin and mucous membrane colouring, well hydrated with good peripheral perfusion. Brachial and femoral pulses palpable symmetrical. Normal PCA. No signs of respiratory distress. The rest of the systematic examination was normal.
-During the examination coughing access is present, with final inspiratory rooster, coinciding with crying.

COMPLEMENTARY TESTS:
Rapid detection of Respiratory Syncytial Virus (RSV) antigen: negative.
Haemogram with 11,800/mm3 leukocytes (neutrophils: 3,700/mm3, lymphocytes: 7,000/mm3), Hb 9.9g/dl, Hct 29.1%. Platelets 505,000/mm3. Rest normal. Biochemistry normal. C-reactive protein 1.1 mg/l.
In view of the mother's symptoms, a PCR for Bordetella pertussis in nasopharyngeal exudate was performed and was positive.

Chemoprophylaxis (CP) and treatment
The infant was hospitalised in the infant unit for monitoring and received treatment with Clarithromycin 7.5 mg/kg/12 h O.V. for 7 days. He remained in hospital for 6 days, the first 72 hours he presented apnoea with hyposaturation and nasogastric tube feeding, then progressively evolved favourably, with no other significant incidents.
The mother was diagnosed and treated with Clarithromycin 500 mg/12 h, 7 days.
-Preventive Medicine was informed of these two cases confirmed with PCR for B. pertussis and chemoprophylaxis of the cohabitants with Clarithromycin was carried out.

